Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation. Eur J Hum Genet

Institute for Human Genetics, University of Luebeck, Ratzeburger Allee 160, Luebeck, Germany.
European journal of human genetics: EJHG (Impact Factor: 4.35). 03/2010; 18(8):965-8. DOI: 10.1038/ejhg.2010.40
Source: PubMed

ABSTRACT Autosomal dominantly inherited spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative disorders primarily affecting the cerebellum. Genetically, 26 different loci have been identified so far, although the corresponding gene has not yet been determined for 10 of them. Recently, mutations in the ATPase family gene 3-like 2 gene were presented to cause SCA type 28. To define the frequency of SCA28 mutations, we performed molecular genetic analyses in 140 unrelated familial cases with ataxia. Among other variations, we found a novel missense mutation at an evolutionarily conserved amino-acid position using a single-strand conformation polymorphism approach, followed by DNA sequencing. This amino-acid exchange p.E700K was detected in a four-generation German family and was not observed in a survey of 400 chromosomes from healthy control individuals.

Download full-text


Available from: Zacharias Kohl, Sep 29, 2015
1 Follower
32 Reads
  • Source
    • "SCA28 is one of the more recently identified forms, and is associated with mutations in AFG3L2 (ATPase family gene 3-like 2) on chromosome 18p [2,3]. All mutations so far reported are missense changes, all are located in the M41-protease domain of the AFG3L2 protein with the exception of one (p.Asn432Thr) [3-5]. The disease prevalence is around 1.5% among SCA patients of European descent [2-4]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background SCA28 is an autosomal dominant ataxia associated with AFG3L2 gene mutations. We performed a whole genome expression profiling using lymphoblastoid cell lines (LCLs) from four SCA28 patients and six unrelated healthy controls matched for sex and age. Methods Gene expression was evaluated with the Affymetrix GeneChip Human Genome U133A 2.0 Arrays and data were validated by real-time PCR. Results We found 66 genes whose expression was statistically different in SCA28 LCLs, 35 of which were up-regulated and 31 down-regulated. The differentially expressed genes were clustered in five functional categories: (1) regulation of cell proliferation; (2) regulation of programmed cell death; (3) response to oxidative stress; (4) cell adhesion, and (5) chemical homeostasis. To validate these data, we performed functional experiments that proved an impaired SCA28 LCLs growth compared to controls (p < 0.005), an increased number of cells in the G0/G1 phase (p < 0.001), and an increased mortality because of apoptosis (p < 0.05). We also showed that respiratory chain activity and reactive oxygen species levels was not altered, although lipid peroxidation in SCA28 LCLs was increased in basal conditions (p < 0.05). We did not detect mitochondrial DNA large deletions. An increase of TFAM, a crucial protein for mtDNA maintenance, and of DRP1, a key regulator of mitochondrial dynamic mechanism, suggested an alteration of fission/fusion pathways. Conclusions Whole genome expression profiling, performed on SCA28 LCLs, allowed us to identify five altered functional categories that characterize the SCA28 LCLs phenotype, the first reported in human cells to our knowledge.
    BMC Medical Genomics 06/2013; 6(1):22. DOI:10.1186/1755-8794-6-22 · 2.87 Impact Factor
  • Source
    • "In addition, they perform proteolytic cleavage of substrates, which are the nuclear-encoded subunit of mitochondrial ribosomes MrpL32 and the regulator of mitochondrial fusion OPA1 (6,7). Both paraplegin and AFG3L2 have been linked to neurodegenerative disorders: mutations in the paraplegin-coding gene cause a recessive form of hereditary spastic paraplegia (8), while heterozygous and homozygous mutations in AFG3L2 have been associated to spinocerebellar ataxia type 28 (SCA28) (9–11) and to a novel progressive myoclonic epilepsy-ataxia-polyneuropathy syndrome of childhood, respectively (12). Whether these diverse diseases reflect tissue-specific expression level of paraplegin and AFG3L2 (13) or different substrate specificity of the two proteases remain to be clarified. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The mitochondrial protein AFG3L2 forms homo-oligomeric and hetero-oligomeric complexes with paraplegin in the inner mitochondrial membrane, named m-AAA proteases. These complexes are in charge of quality control of misfolded proteins and participate in the regulation of OPA1 proteolytic cleavage, required for mitochondrial fusion. Mutations in AFG3L2 cause spinocerebellar ataxia type 28 and a complex neurodegenerative syndrome of childhood. In this study, we demonstrated that the loss of AFG3L2 in mouse embryonic fibroblasts (MEFs) reduces mitochondrial Ca(2+) uptake capacity. This defect is neither a consequence of global alteration in cellular Ca(2+) homeostasis nor of the reduced driving force for Ca(2+) internalization within mitochondria, since cytosolic Ca(2+) transients and mitochondrial membrane potential remain unaffected. Moreover, experiments in permeabilized cells revealed unaltered mitochondrial Ca(2+) uptake speed in Afg3l2(-/-) cells, indicating the presence of functional Ca(2+) uptake machinery. Our results show that the defective Ca(2+) handling in Afg3l2(-/-) cells is caused by fragmentation of the mitochondrial network, secondary to respiratory dysfunction and the consequent processing of OPA1. This leaves a number of mitochondria devoid of connections to the ER and thus without Ca(2+) elevations, hampering the proper Ca(2+) diffusion along the mitochondrial network. The recovery of mitochondrial fragmentation in Afg3l2(-/-) MEFs by overexpression of OPA1 rescues the impaired mitochondrial Ca(2+) buffering, but fails to restore respiration. By linking mitochondrial morphology and Ca(2+) homeostasis, these findings shed new light in the molecular mechanisms underlining neurodegeneration caused by AFG3L2 mutations.
    Human Molecular Genetics 06/2012; 21(17):3858-70. DOI:10.1093/hmg/dds214 · 6.39 Impact Factor
  • Source
    • "The nature of the identified mutations is suggestive that they may trigger pathogenesis by both dominant-negative and loss of function mechanisms. A p.E700K missense mutation within the AFG3L2 gene has been identified in a German family with early onset and slow progression (Edener et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The spinocerebellar ataxias (SCAs) are a clinically, genetically and neuropathologically heterogeneous group of neurological disorders defined by variable degrees of cerebellar ataxia often accompanied by additional cerebellar and noncerebellar symptoms that, in many cases, defy differentiation based on clinical characterisation alone. The clinical symptoms are triggered by neurodegeneration of the cerebellum and its rely connections. Currently, there are 43 different genes associated with the autosomal dominant SCAs identified. Genetic studies refine the clinical diagnosis, provide molecular testing of at risk, a/presymptomatic, prenatal or preimplantation and facilitate genetic counselling in 27 SCA subtypes. Recent scientific advances are shedding light into the altered molecular pathways involved and the mechanisms by which the mutant gene products underlie neurodegeneration. This knowledge should be translated into effectively developing selective therapeutic strategies. The scope of this chapter is to provide an updated summary of the genetic aspects of the autosomal dominant SCAs. Key Concepts: Ataxia, a term that derives from the Greek, is a neurological disorder characterised by loss of control of voluntary body movements.Spinocerebellar ataxias, also known as SCAs, are a highly heterogeneous group of neurodegenerative diseases caused by cerebellar atrophy triggered by predominant loss of Purkinje cells in the cerebellum.The term ‘spinocerebellar ataxias’ is commonly used for those inherited progressive, congenital or episodic ataxias presenting an autosomal dominant inheritance.Mutations presenting incomplete penetrance in at least 43 genes are responsible for ataxia in the autosomal dominant SCAs.CAG repeat expansions encoding for polyglutamines in the gene products currently underlie neurodegeneration in seven spinocerebellar ataxia subtypes.Anticipation is a genetic phenomenon whereby the clinical symptoms become apparent at an earlier age as it is passed on to the next generation. This is associated with the germline transmission of an unstable expanded CAG-triplet repeat.Keywords:spinocerebellar ataxias;cerebellum;neurodegeneration;movement disorders;Purkinje cells;polyglutamine expansions;molecular diagnosis;genetic counselling;ataxia scales
    10/2011; John Wiley & Sons.
Show more